Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guduchi Ghan Vati in Asymptomatic COVID-19
NCT04542876Completed
- Sponsor
- AarogyaAI
- Start
- May 2020
- Primary completion
- Jul 2020
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of Guduchi Ghan Vati in coronavirus disease 2019 (COVID-19), sponsored by AarogyaAI. Primary endpoint: Virologic clearance at 14 days. Started May 2020; status: completed.
02
Drugs
Guduchi Ghan Vati
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04542876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04542876.